Growth Metrics

Agilon Health (AGL) Gains from Sales and Divestitures (2022)

Agilon Health's Gains from Sales and Divestitures history spans 1 years, with the latest figure at $404000.0 for Q4 2022.

  • For Q4 2022, Gains from Sales and Divestitures changed N/A year-over-year to $404000.0; the TTM value through Dec 2022 reached $404000.0, changed N/A, while the annual FY2022 figure was $404000.0, N/A changed from the prior year.
  • Gains from Sales and Divestitures reached $404000.0 in Q4 2022 per AGL's latest filing.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $404000.0 in Q4 2022 to a low of $404000.0 in Q4 2022.